In recent studies on asthma, anti-IL-5 therapy has been shown to slow the exacerbation of eosinophilic severe asthma, IL-8 antagonism can be used in the treatment of asthma, and COX-2 is also associated with allergic asthma [41–43]. The gene discussed is IL5; the disease is allergic asthma.